NASDAQ:OSUR

OraSure Technologies (OSUR) Stock Forecast, Price & News

$5.91

0.00 (0.00%)

(As of 12:39 PM ET)

Compare

Today's Range: $5.85
▼
$5.96
50-Day Range: $4.49
▼
$6.91
52-Week Range: $3.56
▼
$7.82

Volume: 114,571 shs
Average Volume: 605,712 shs
Market Capitalization: $433.91 million

P/E Ratio: 10.19
Dividend Yield: N/A
Price Target: $5.00

OraSure Technologies MarketRank™ Forecast

Analyst Rating: 0.00 Rating Score
Upside/Downside: 15.1% Downside
$5.00 Price Target
Short Interest: Healthy
3.31% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.09
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Decreasing
From $0.33 to ($0.31) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

876th out of 965 stocks

Surgical & Medical Instruments Industry

91st out of 99 stocks

0.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $5.00, OraSure Technologies has a forecasted downside of 15.1% from its current price of $5.89.
Amount of Analyst Coverage
OraSure Technologies has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
3.31% of the float of OraSure Technologies has been sold short.
Short Interest Ratio / Days to Cover
OraSure Technologies has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in OraSure Technologies has recently decreased by 5.31%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
OraSure Technologies does not currently pay a dividend.
Dividend Growth
OraSure Technologies does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
OraSure Technologies has received a 61.52% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "DNA sequencers", "Genomics analysis tools", and "Respiratory tract infection tests" products. See details.
Environmental Sustainability
The Environmental Impact score for OraSure Technologies is -1.09.

2.9

News and Social Media Coverage

News Sentiment
OraSure Technologies has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for OraSure Technologies this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for OSUR on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
80 people have added OraSure Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 1,500% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OraSure Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.20% of the stock of OraSure Technologies is held by insiders.
Percentage Held by Institutions
88.76% of the stock of OraSure Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for OraSure Technologies are expected to decrease in the coming year, from $0.33 to ($0.31) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of OraSure Technologies is 10.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.43.
Price to Earnings Ratio vs. Sector
The P/E ratio of OraSure Technologies is 10.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 97.19.
Price to Book Value per Share Ratio
OraSure Technologies has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgeneGUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

OSUR Price History

30 days | 90 days | 365 days | Advanced Chart

OSUR Stock News Headlines

September 29, 2023 | americanbankingnews.com

OraSure Technologies (NASDAQ:OSUR) Shares Cross Above Two Hundred Day Moving Average of $5.83

September 25, 2023 | finance.yahoo.com

Is This Why OraSure Technologies, Inc. Is Tanking Today?

October 4, 2023 | Oxford Club (Ad)

Better Than Oil Stocks

The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.

August 12, 2023 | markets.businessinsider.com

J.P. Morgan Remains a Hold on Orasure Technologies (OSUR)

August 9, 2023 | finance.yahoo.com

Industry Analysts Just Made A Sizeable Upgrade To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts

August 6, 2023 | seekingalpha.com

OraSure Technologies: Spikes On Strong Q2 Results And Guidance

August 5, 2023 | finance.yahoo.com

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Intrinsic Value Is Potentially 57% Above Its Share Price

August 4, 2023 | seekingalpha.com

OraSure up 31% on Q3 revenue outlook, Q2 results

October 4, 2023 | Behind the Markets (Ad)

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"

The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>

August 4, 2023 | finance.yahoo.com

Q2 2023 OraSure Technologies Inc Earnings Call

August 3, 2023 | finance.yahoo.com

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

August 3, 2023 | benzinga.com

Earnings Preview: OraSure Technologies

July 20, 2023 | finance.yahoo.com

OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd

July 18, 2023 | msn.com

Stephens & Co. Maintains Orasure Technologies (OSUR) Equal-Weight Recommendation

July 4, 2023 | fool.com

OraSure Technologies (NASDAQ: OSUR)

June 30, 2023 | ca.finance.yahoo.com

OSUR - OraSure Technologies, Inc.

June 29, 2023 | finance.yahoo.com

OraSure Technologies' (NASDAQ:OSUR) investors will be pleased with their favorable 82% return over the last year

June 13, 2023 | finance.yahoo.com

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

June 8, 2023 | finance.yahoo.com

OraSure Technologies (NASDAQ:OSUR) Has More To Do To Multiply In Value Going Forward

June 2, 2023 | msn.com

OraSure Technologies' CFO Makes Bold Insider Purchase, Reigniting Investor Confidence

May 16, 2023 | finance.yahoo.com

Time To Worry? Analysts Just Downgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Outlook

May 12, 2023 | msn.com

Recap: OraSure Technologies Q1 Earnings

May 12, 2023 | finance.yahoo.com

Can Mixed Fundamentals Have A Negative Impact on OraSure Technologies, Inc. (NASDAQ:OSUR) Current Share Price Momentum?

May 11, 2023 | finance.yahoo.com

Q1 2023 OraSure Technologies Inc Earnings Call

May 10, 2023 | finance.yahoo.com

OraSure Technologies (OSUR) Q1 Earnings and Revenues Beat Estimates

May 10, 2023 | finance.yahoo.com

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

May 10, 2023 | finance.yahoo.com

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

See More Headlines

Receive OSUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter.

OSUR Company Calendar

Last Earnings: 8/03/2023
Today: 10/04/2023
Next Earnings (Estimated): 11/14/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:OSUR
CUSIP: 68554V10
CIK: 1116463
Web: www.orasure.com
Phone: (610) 882-1820
Fax: 610-882-1830
Employees: 840
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $5.00
High Stock Price Forecast: $5.00
Low Stock Price Forecast: $5.00
Forecasted Upside/Downside: -15.0%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.58
Trailing P/E Ratio: 10.14
Forward P/E Ratio: 17.82
P/E Growth: N/A
Net Income: $-17,930,000.00
Net Margins: 9.01%
Pretax Margin: 8.61%
Return on Equity: 11.58%
Return on Assets: 9.67%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.36
Quick Ratio: 5.78

Sales & Book Value

Annual Sales: $387.48 million
Price / Sales: 1.11
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.01 per share
Price / Book: 1.17

Miscellaneous

Outstanding Shares: 73,420,000
Free Float: 71,800,000
Market Cap: $431.71 million
Optionable: Optionable
Beta: 0.05

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Ms. Carrie Eglinton Manner (Age 48)
Pres, CEO & Director
Comp: $1.42M

Mr. Kenneth J. McGrath (Age 51)
Chief Financial Officer
Comp: $701.58k

Ms. Kathleen Gallagher Weber (Age 56)
Chief Product Officer
Comp: $890.87k

Ms. Michele Anthony (Age 48)
Sr. VP, Chief Accounting Officer, Controller & Assistant Sec.

Mr. Rafal Iwasiow Ph.D.
VP of Science, Innovation & Technology

Mr. Stefano Taucer
Gen. Counsel & Corp. Sec.

Mr. David A. Rappaport C.F.A.
CFA, Sr. VP Corp. Devel., Strategy & Integration

Amy Steigerwalt
Sr. VP of HR

Mr. Zachary Wert
Sr. VP of Global Operations

Ms. Trace Custer
Sr. VP of Quality & Regulatory

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

OSUR Stock - Frequently Asked Questions

What is OraSure Technologies' stock price forecast for 2023?: 0 brokers have issued 12 month target prices for OraSure Technologies' shares. Their OSUR share price forecasts range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next year. This suggests that the stock has a possible downside of 15.0%.
View analysts price targets for OSUR or view top-rated stocks among Wall Street analysts.
How have OSUR shares performed in 2023?: OraSure Technologies' stock was trading at $4.82 at the start of the year. Since then, OSUR shares have increased by 22.0% and is now trading at $5.88.
View the best growth stocks for 2023 here.
When is OraSure Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our OSUR earnings forecast.
How were OraSure Technologies' earnings last quarter?: OraSure Technologies, Inc. (NASDAQ:OSUR) posted its earnings results on Thursday, August, 3rd. The medical instruments supplier reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The medical instruments supplier had revenue of $85.44 million for the quarter, compared to analysts' expectations of $64.30 million. OraSure Technologies had a net margin of 9.01% and a trailing twelve-month return on equity of 11.58%.
What ETF holds OraSure Technologies' stock ?: ETFMG Treatments Testing and Advancements ETF holds 20,685 shares of OSUR stock, representing 0.92% of its portfolio.
What guidance has OraSure Technologies issued on next quarter's earnings?: OraSure Technologies updated its third quarter 2023 earnings guidance on Friday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $72.00 million-$77.00 million, compared to the consensus revenue estimate of $48.91 million.

What is Stephen Tang's approval rating as OraSure Technologies' CEO?: 2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of OraSure Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).
What is OraSure Technologies' stock symbol?: OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."
How do I buy shares of OraSure Technologies?: Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is OraSure Technologies' stock price today?: One share of OSUR stock can currently be purchased for approximately $5.88.
How much money does OraSure Technologies make?: OraSure Technologies (NASDAQ:OSUR) has a market capitalization of $431.71 million and generates $387.48 million in revenue each year. The medical instruments supplier earns $-17,930,000.00 in net income (profit) each year or $0.58 on an earnings per share basis.
How many employees does OraSure Technologies have?: The company employs 840 workers across the globe.
How can I contact OraSure Technologies?: OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The official website for the company is www.orasure.com. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at investorinfo@orasure.com, or via fax at 610-882-1830.

This page (NASDAQ:OSUR) was last updated on 10/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

OraSure Technologies (OSUR) Stock Forecast, Price & News

OraSure Technologies MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About OraSure Technologies (NASDAQ:OSUR) Stock

OSUR Price History

OSUR Stock News Headlines

OSUR Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

OSUR Stock - Frequently Asked Questions

Overall MarketRank^™